| Literature DB >> 35206155 |
Juliane Rackerseder1, Carolin Hornbach1, Peter Dicks2,3, Hedy Kerek-Bodden4, Theresia Krieger1.
Abstract
High-quality and user-friendly patient information material (PIM) is essential for understanding and accepting a new care programme. When optimising the PIM of the integrated, cross-sectoral psycho-oncological (isPO) care programme, the design of the fifth element of the patient information strategy-the patient-friendly website-was still pending. In this paper, the iterative design process of the patient-friendly isPO website is described. We applied the participatory health research (PHR) approach to enable high levels of participation of its respective end-users (e.g., cancer survivors), service providers, and experts. The design included six steps: (1) initiation, (2) planning, (3) initial idea exploration, (4) creation of a first working version, (5) three optimisation loops, and (6) dissemination. An exploratory mixed-methods design has been used. Qualitative data collection included document analysis, interviews, and participatory action research (PAR) loops with focus groups. Finally, the quality of the newly designed website was quantitatively assessed with the UPIM-Check, a user-friendly instrument for assessing and optimising PIM. The PHR approach was indispensable for the design of our needs-oriented, patient-friendly website. Participants' high levels of participation strongly contributed to the products' quality. The final descriptive statistical evaluation shows that the final website was rated very good on average by its end-users.Entities:
Keywords: cancer; participatory health research; patient engagement; patient information material; patient-friendly website; piloting; quality assessment; website design
Mesh:
Year: 2022 PMID: 35206155 PMCID: PMC8872440 DOI: 10.3390/ijerph19041969
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1The six participation levels of the participatory health research approach (own figure, adapted from Cornwall, 1996).
Characteristics of the study participants.
| Participant and Background | Sex (F/M) | Type (I/FG) | Setting/Affiliation |
|---|---|---|---|
| F | Interview | Johanna Etienne Hospital Neuss | |
| M | Interview | University Hospital of Cologne | |
| F | Interview | Maria Hilf Hospital Mönchengladbach | |
| F | Interview | University Hospital of Cologne | |
| F ( | Focus Group | Members of KG NRW | |
| F | Interview | Member of the House of Cancer Self-Help | |
| F | Interview | Member of the House of Cancer Self-Help | |
| M | Interview | Member of the District Association of Laryngectomists Aachen e.V. | |
| F | Interview | Member of the District Association of Laryngectomists Aachen e.V. | |
| M | Interview | Member of the District Association of Laryngectomists Aachen e.V. | |
| F ( | Focus Group | University Hospital of Cologne, Johanna Etienne Hospital Neuss, |
Figure 2The research process of the website design.
Outcomes of the document analysis: description of the isPO PIM and its website suitability.
| isPO PIM | Utilisation in isPO | Content | Design Features | Suitable Element for Utilisation on the Patient-Friendly Website |
|---|---|---|---|---|
| Poster | For all patients (e.g., in the waiting room) | Mention of rough key data; the description in key points; call to address in case of interest | Tree motif; green colour scheme; isPO logo |
Tree motif Slogan “Cancer diagnosis? We accompany you on your way!” isPO logo |
| Leaflet | For potential isPO patients and interested parties | Explanation of what isPO is, what the care looks like, what patients receive in the care; specific contacts | Tree motif; green colour design |
Title of the flyer “Psycho-oncological support, counselling, treatment for patients with an initial diagnosis of cancer” The structure of the flyer (What is it? What does care look like? Who can participate? Contact persons) Flyer could be linked to the website as a document |
| Patient information folder | The potential isPO patients receive the patient map during the educational talk | Information on the isPO care programme and the isPO study | Four-page information map with isPO logo |
Explanation of the questionnaires to determine the individual need for psycho-oncological support Very comprehensible information about the programme and study |
| “One-Pager” (study information overview) | isPO patients receive the one-pager when enrolling in the study | Description of the isPO study | Coloured timeline of the isPO programme and isPO study |
Timeline presentation with different colours for programme and study Present the meaning of the evaluation study topic data protection |
Figure 3Final shape of the patient-friendly isPO website.
Descriptive statistical evaluation of the UPIM-Checks.
| Correctness & Validity of Content - Does the Content Seem to Be Correct? Does the Information Appear to Be Valid? | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | Q1.1 | Q1.2 | Q1.3 | Q1.4 | Q1.5 | Q1.6 | Q1.7 | Q1.8 | Q1.9 | ||
|
| 44.4% | 60.0% | 50.0% | 80.0% | 30.0% | 70.0% | 40.0% | 40.0% | 20.0% | 10.0% | |
|
| 24.4% | 20.0% | 20.0% | 0.0% | 40.0% | 0.0% | 20.0% | 30.0% | 40.0% | 50.0% | |
|
| 17.8% | 0.0% | 20.0% | 10.0% | 10.0% | 20.0% | 30.0% | 10.0% | 30.0% | 30.0% | |
|
| 13.3% | 20.0% | 10.0% | 10.0% | 20.0% | 10.0% | 10.0% | 20.0% | 10.0% | 10.0% | |
|
| |||||||||||
|
|
|
|
|
|
|
|
|
| |||
|
| 50.0% | 50.0% | 60.0% | 70.0% | 60.0% | 30.0% | 60.0% | 50.0% | 20.0% | ||
|
| 25.0% | 30.0% | 10.0% | 10.0% | 20.0% | 50.0% | 20.0% | 40.0% | 20.0% | ||
|
| 10.0% | 20.0% | 20.0% | 10.0% | 10.0% | 0.0% | 10.0% | 0.0% | 10.0% | ||
|
| 15.0% | 0.0% | 10.0% | 10.0% | 10.0% | 20.0% | 10.0% | 10.0% | 50.0% | ||
|
| |||||||||||
|
|
|
|
|
| |||||||
|
| 70.0% | 80.0% | 80.0% | 80.0% | 40.0% | ||||||
|
| 17.5% | 10.0% | 10.0% | 10.0% | 40.0% | ||||||
|
| 2.5% | 0.0% | 0.0% | 0.0% | 10.0% | ||||||
|
| 10.0% | 10.0% | 10.0% | 10.0% | 10.0% | ||||||
|
| |||||||||||
|
|
|
|
|
|
|
|
|
|
|
| |
|
| 70.0% | 50.0% | 70.0% | 70.0% | 70.0% | 70.0% | 60.0% | 70.0% | 80.0% | 90.0% | 70.0% |
|
| 12.0% | 20.0% | 0.0% | 10.0% | 10.0% | 10.0% | 20.0% | 20.0% | 10.0% | 0.0% | 20.0% |
|
| 7.0% | 30.0% | 10.0% | 10.0% | 10.0% | 10.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
|
| 11.0% | 0.0% | 20.0% | 10.0% | 10.0% | 10.0% | 20.0% | 10.0% | 10.0% | 10.0% | 10.0% |